From the FDA Drug Label
Erythrasma: In the treatment of infections due to Corynebacterium minutissimum Erythromycin is indicated for the treatment of Erythrasma, which is caused by Corynebacterium minutissimum 1.
- The drug is effective in treating this infection.
- Erythromycin can be used to treat Erythrasma.
From the Research
Erythrasma is best treated with topical 2% mupirocin ointment applied twice daily, as it has been shown to lead to the resolution of the infection in a recent case report 2. The treatment of erythrasma, a bacterial infection of the skin caused by Corynebacterium minutissimum, typically involves the use of topical or oral antibiotics.
- The most recent and highest quality study, a case report from 2020, found that twice daily topical 2% mupirocin ointment therapy led to the resolution of erythrasma 2.
- Another study from 2017 also found that mupirocin 2% ointment monotherapy was effective in treating erythrasma, with complete resolution of the infection occurring in all nine patients treated 3.
- Other treatment options, such as erythromycin and clindamycin, have also been shown to be effective in treating erythrasma, but the most recent and highest quality study supports the use of topical 2% mupirocin ointment 4, 5. It is also important to keep the affected areas dry and to wear loose-fitting, breathable clothing to help prevent the recurrence of the infection.
- Washing with antibacterial soaps containing benzoyl peroxide or chlorhexidine can also help speed recovery 4.
- Changing socks daily if feet are affected can also help prevent the recurrence of the infection. Overall, the treatment of erythrasma should be tailored to the individual patient and should take into account the severity of the infection and the patient's medical history.